Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (HKG:2566)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
6.83
-0.16 (-2.29%)
At close: May 7, 2026

HKG:2566 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
348.67537.6393.1871.5494.83
Short-Term Investments
365.7973.7532.9744.4432.97
Cash & Short-Term Investments
714.47611.38126.14115.98127.8
Cash Growth
16.86%384.68%8.76%-9.25%-
Accounts Receivable
601.77635.8522.11454.8393.98
Other Receivables
3.632.974.145.3414.84
Receivables
605.4638.77526.24460.14408.82
Inventory
155.46149.12169.81171.9201.53
Other Current Assets
7.8410.717.5410.749.75
Total Current Assets
1,4831,410839.74758.76747.91
Property, Plant & Equipment
399.84354.23373.56385.8397.93
Other Intangible Assets
0.140.921.050.190.34
Long-Term Deferred Charges
208.36156.8990.365.630.45
Other Long-Term Assets
26.4813.053.246.58
Total Assets
2,1181,9231,3081,2141,183
Accounts Payable
49.0827.6443.2452.5466.85
Accrued Expenses
83.0168.8766.455.3250.03
Current Portion of Long-Term Debt
45.4981.01130.84141.53157.56
Current Portion of Leases
3.450.940.770.330.31
Current Income Taxes Payable
7.1414.370.44--
Current Unearned Revenue
22.4823.614.8116.8921.21
Other Current Liabilities
121.75125.2591.0289.31104.56
Total Current Liabilities
332.39341.69347.52355.93400.52
Long-Term Debt
57.0638.7734.5278.7345.81
Long-Term Leases
55.62-0.94-0.33
Long-Term Unearned Revenue
6.26.067.277.562.5
Long-Term Deferred Tax Liabilities
15.4816.519.564.8413.29
Other Long-Term Liabilities
32-0.342.62
Total Liabilities
469.74405.01409.8447.4465.06
Common Stock
245.4245.420053.4553.45
Additional Paid-In Capital
1,1121,112681.43--
Retained Earnings
275.43150.7612.16673.73625.86
Comprehensive Income & Other
15.159.64.339.0138.83
Shareholders' Equity
1,6481,518897.89766.18718.14
Total Liabilities & Equity
2,1181,9231,3081,2141,183
Total Debt
161.62120.72167.07220.58204
Net Cash (Debt)
552.85490.66-40.93-104.6-76.2
Net Cash Growth
12.67%----
Net Cash Per Share
2.252.40-0.20-0.52-0.38
Filing Date Shares Outstanding
245.4245.4200200200
Total Common Shares Outstanding
245.4245.4200200200
Working Capital
1,1511,068492.22402.82347.39
Book Value Per Share
6.726.194.493.833.59
Tangible Book Value
1,6481,517896.84765.99717.79
Tangible Book Value Per Share
6.726.184.483.833.59
Buildings
280.55276.41274.03271.85268.73
Machinery
329.23319.44307.57290.15271.78
Construction In Progress
10.010.240.691.850.36
Source: S&P Global Market Intelligence. Standard template. Financial Sources.